Guest Post: Twenty years in, Singapore still searches for its biotech success story

In 2000, the Singapore government laid out $2b over five years as part of an initial push to catapult into a biotech hub.

Related Keywords

Berkeley ,California ,United States ,Stanford University ,Massachusetts Institute Of Technology ,Massachusetts ,China ,Zurich ,Züsz ,Switzerland ,Boston ,San Francisco ,National University Of Singapore ,Singapore General ,Singapore ,Stanford ,New Jersey ,Chinese ,Irene Cheong ,Benjamin Toh ,John Connolly ,Aum Biosciences ,Outram Bio ,Stephen Sunderland ,Damian Oconnell ,Takeda Asia Pacific ,Thomas Willemsen ,Parker Institute For Cancer Immunotherapy ,Novo Holdings ,Novartis ,Nasdaq ,Mountain Crest Acquisition Corp ,Temasek ,Experimental Drug Development Centre ,National Biomedical Science Strategy ,Economic Development Board ,Duke University ,Boehringer Ingelheim ,Singapore Agency For Science ,Aslan Pharmaceuticals ,Novartis Institute For Tropical Diseases ,Stanford Byers Center ,University Of California ,National Biomedical Science ,Christopher Tan ,Guy Heathers ,Tessa Therapeutics ,Albatroz Therapeutics ,Nasdaq Listed Mountain Crest Acquisition Corp ,Big Pharma ,Damiano Connell ,Drug Development Centre ,Hummingbird Bioscience ,Greater Boston ,Southeast Asia ,National University ,Talent Gaps ,Singapore Biodesign ,Parker Institute ,Novartis Institute ,Tropical Diseases ,Wuxi Biologics ,